Table 3.

Characteristics of Benzodiazepines (BZ) Users Who Obtained Any BZs through a Healthcare Diversion Source (n = 1,207)

Demographics	Used Healthcare Sources				OR[95%]	p
	Yes(n = 251)		No (n = 956)
	%	n	%	n
Gender+					1.06 [.80, 1.42]	ns
Male(ref)	20	155	80	604
Female	21	95	79	348
Age
18–25 (ref)	18	52	82	230
26–35	27	95	73	256	1.64 [1.12,2.41]	.011
36–46	20	66	80	269	1.09 [0.73, 1.63]	ns
47+	16	38	84	201	0.84 [0.53, 1.32]	ns
Race/Ethnicity
White (ref)	27	162	73	436
African-American	13	35	87	241	0.39 [.26, .58]	.001
Hispanic	16	44	84	233	0.51 [.35, .74]	.001
Other	18	10	82	46	0.59 [.29, 1.19]	ns
Group
In-treatment, Private (ref)
In-treatment, Public	33	75	67	153
Methadone	19	46	81	199	0.47 [.31, .72]	.001
MSM	20	50	80	197	0.52 [.34, .78]	.002
Street Users	23	56	77	193	0.59 [.39, .89]	.011
	10	24	90	214	0.23 [.14, .38]	.001
Income					1.96 [1.47, 2.60]	.008
< $1,000 (ref)	15	94	85	516
$1000 or more	26	157	74	440
Health Insurance+					1.89[1.43, 2.51]	.001
Yes	26	151	74	422
No (ref)	16	100	84	529

Ref = reference group;

⁺missing data from 5 participants